Page 75 - Read Online

Page 22 of 23 Poznyak et al. Microbiome Res Rep. 2026;5:3

171. Purdel C, Margină D, Adam-Dima I, Ungurianu A. The beneficial effects of dietary interventions on gut microbiota-an up-to-date critical
review and future perspectives. Nutrients. 2023;15:5005. DOI PubMed PMC
172. Mitra S, Munni YA, Dash R, et al. Gut microbiota in autophagy regulation: new therapeutic perspective in neurodegeneration. Life
(Basel). 2023;13:957. DOI PubMed PMC
173. Niechcial A, Schwarzfischer M, Wawrzyniak M, et al. Spermidine ameliorates colitis via induction of anti-inflammatory macrophages
and prevention of intestinal dysbiosis. J Crohns Colitis. 2023;17:1489-503. DOI PubMed PMC
174. Larabi A, Barnich N, Nguyen HTT. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in
IBD. Autophagy. 2020;16:38-51. DOI PubMed PMC
175. Xuan H, Ou A, Hao S, Shi J, Jin X. Galangin protects against symptoms of dextran sodium sulfate-induced acute colitis by activating
autophagy and modulating the gut microbiota. Nutrients. 2020;12:347. DOI PubMed PMC
176. Fu R, Wang L, Meng Y, et al. Apigenin remodels the gut microbiota to ameliorate ulcerative colitis. Front Nutr. 2022;9:1062961. DOI
PubMed PMC
177. Ermencheva P, Kotov G, Shumnalieva R, Velikova T, Monov S. Exploring the role of the microbiome in rheumatoid arthritis-a critical
review. Microorganisms. 2024;12:1387. DOI PubMed PMC
178. Ghosh S, Whitley CS, Haribabu B, Jala VR. Regulation of intestinal barrier function by microbial metabolites. Cell Mol Gastroenterol
Hepatol. 2021;11:1463-82. DOI PubMed PMC
179. Fu Y, Lyu J, Wang S. The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective.
Front Immunol. 2023;14:1277102. DOI PubMed PMC
180. Engevik MA, Herrmann B, Ruan W, et al. Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell
stress and reduces TNBS-driven colonic inflammation. Gut Microbes. 2021;13:1-21. DOI PubMed PMC
181. Jian H, Liu Y, Wang X, Dong X, Zou X. Akkermansia muciniphila as a next-generation probiotic in modulating human metabolic
homeostasis and disease progression: a role mediated by gut-liver-brain axes? Int J Mol Sci 2023;24:3900. DOI PubMed PMC
182. Wang SL, Shao BZ, Zhao SB, et al. Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel
disease. Cell Death Dis. 2019;10:391. DOI PubMed PMC
183. Ke P, Shao BZ, Xu ZQ, Chen XW, Liu C. Intestinal autophagy and its pharmacological control in inflammatory bowel disease. Front
Immunol. 2016;7:695. DOI PubMed PMC
184. Lapaquette P, Bizeau JB, Acar N, Bringer MA. Reciprocal interactions between gut microbiota and autophagy. World J Gastroenterol.
2021;27:8283-301. DOI PubMed PMC
185. Arab HH, Al-Shorbagy MY, Saad MA. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental
inflammatory bowel disease in rats: targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways. Chem Biol Interact.
2021;335:109368. DOI PubMed
186. Zhang W, Zou M, Fu J, Xu Y, Zhu Y. Autophagy: A potential target for natural products in the treatment of ulcerative colitis. Biomed
Pharmacother. 2024;176:116891. DOI
187. Buruiană A, Florian ȘI, Florian AI, et al. The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive
negotiations. Int J Mol Sci. 2020;21:1950. DOI PubMed PMC
188. Zhang Y, Yang M, Xie H, Hong F, Yang S. Role of miRNAs in rheumatoid arthritis therapy. Cells. 2023;12:1749. DOI PubMed PMC
189. Cunningham CC, Wade S, Floudas A, et al. Serum miRNA signature in rheumatoid arthritis and “at-risk individuals”. Front Immunol.
2021;12:633201. DOI PubMed PMC
190. Kmiołek T, Paradowska-Gorycka A. miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis. Cells.
2022;11:452. DOI PubMed PMC
191. Datta N, Johnson C, Kao D, et al. MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis. Pharmacol
Res. 2023;194:106870. DOI
192. Gu L, Ren F, Fang X, Yuan L, Liu G, Wang S. Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut
microbiota composition, barrier function, and inflammatory status in an experimental colitis model. Front Med (Lausanne).
2021;8:660614. DOI PubMed PMC
193. Yang F, Ni B, Liu Q, et al. Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the
gut microbiota. Stem Cell Res Ther. 2022;13:475. DOI PubMed PMC
194. Teng Y, Ren Y, Sayed M, et al. Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota. Cell Host Microbe.
2018;24:637-652.e8. DOI PubMed PMC
195. Nikolaieva N, Sevcikova A, Omelka R, Martiniakova M, Mego M, Ciernikova S. Gut microbiota-microRNA interactions in intestinal
homeostasis and cancer development. Microorganisms. 2022;11:107. DOI PubMed PMC